<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00425867</url>
  </required_header>
  <id_info>
    <org_study_id>PAR1 polymorphisms</org_study_id>
    <nct_id>NCT00425867</nct_id>
  </id_info>
  <brief_title>PAR Family Polymorphisms and Placental Invasion Disorders</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <brief_summary>
    <textblock>
      The present study will be undertaken to establish whether genetic variations of PAR1 could be&#xD;
      involved in the occurrence of any of the &quot;placental syndromes&quot; of preterm delivery,&#xD;
      preeclampsia, and/or small for gestational age babies and recurrent pregnancy loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polymorphisms of Protease Activated Receptor 1 and adverse pregnancy outcomes Protease&#xD;
      Activated Receptor 1 (PAR1), the main thrombin receptor on vascular cells (Coughlin,1999),&#xD;
      plays a critical role in orchestrating human placentation based on temporally and spatially&#xD;
      constrained PAR1 expression in the normal invasive trophoblasts (O'Brien et al, 2003) and its&#xD;
      overexpression in pathological invasive trophoblast (Even-Ram et al, 2003).&#xD;
&#xD;
      Various proteases of the PAR family as well as matrix metalloproteinases have been implicated&#xD;
      in ancillary regulation of cancer metastases and tumor-related angiogenesis. PAR1 in&#xD;
      particular has been proposed to be involved in invasive processes of various cancers (Ruf &amp;&#xD;
      Mueller, 2006; Boire et al, 2005). Similarly, it might be surmised that remodeling of the&#xD;
      placenta microenvironment as well as the requisites of trophoblast invasiveness may be PAR1&#xD;
      sensitive (Grisaru-Granovsky et al, 2005). Therefore, one might hypothesize that PAR1 gene&#xD;
      variability may be involved in early placentation and that adverse pregnancy outcomes of the&#xD;
      &quot;placental syndromes&quot; may have their origin in PAR1 dysregulation.&#xD;
&#xD;
      Study Design: This is a prospective case-control pilot study. Subject enrolment and data&#xD;
      collection will be performed via the Admission Service of the Division for Maternal &amp; Fetal&#xD;
      Medicine in a large tertiary obstetrics department in Jerusalem, Israel. Demographic data&#xD;
      including maternal characteristics, past reproductive history, and information about previous&#xD;
      complications during pregnancy, delivery and the neonatal period will be culled. The blood&#xD;
      samples will be collected at routine admission after obtaining informed consent by the&#xD;
      physician on the floor.&#xD;
&#xD;
      Four groups are described: patients with spontaneous preterm delivery of a singleton before&#xD;
      35 weeks of gestation; patients with a singleton pregnancy complicated by preeclampsia&#xD;
      diagnosed according the Working Group Criteria (2000); patients who deliver a small for&#xD;
      gestational age (SGA) singleton defined as a birth weight below the 10th percentile for the&#xD;
      gestational age according to the Israeli growth curves (Dollberg et al, 2005); and for&#xD;
      comparison, patients who deliver a singleton at term with appropriate size for gestational&#xD;
      age. Patients who suffer delivery with intrauterine fetal demise and/or neonates with&#xD;
      malformations will be excluded.&#xD;
&#xD;
      Maternal and umbilical cord blood samples (in 0.11mol/l sodium tri citrate) will be paired.&#xD;
      DNA will be prepared from white blood cells by standard techniques and subsequently stored at&#xD;
      -4°C for batched analysis. The laboratory staff will be blinded as to the clinical status of&#xD;
      the samples.&#xD;
&#xD;
      Polymorphism analysis will be performed for the following polymorphisms of the PAR1 gene:&#xD;
      [-1426CT], [506 insertion of 13 bp],[IVS-14A/T]: as per standard PCR techniques using&#xD;
      appropriate restriction endonucleases (Arnaud et l, 2000).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <completion_date>November 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment>100</enrollment>
  <condition>Miscarriage, Recurrent</condition>
  <condition>Premature Labor</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PAR1 polymoprhisms and placental invasion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with reccurent abortions unexplained&#xD;
&#xD;
          -  Premature delicery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Term pregnancies&#xD;
&#xD;
          -  Abortion that the cause is known&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sorina Grisaru, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaare Zedek Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sorina Grisaru, MD</last_name>
    <phone>97226555111</phone>
    <email>granovsky@netvision.net.il</email>
  </overall_contact>
  <link>
    <url>http://ncbi.nlm.nih.gov</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17100658&amp;query_hl=5&amp;itool=pubmed_docsum</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=17097558&amp;query_hl=5&amp;itool=pubmed_docsum</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16710477&amp;query_hl=15&amp;itool=pubmed_docsum</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16081834&amp;query_hl=15&amp;itool=pubmed_docsum</url>
    <description>Related Info</description>
  </link>
  <verification_date>January 2007</verification_date>
  <study_first_submitted>January 22, 2007</study_first_submitted>
  <study_first_submitted_qc>January 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2007</study_first_posted>
  <last_update_submitted>January 25, 2007</last_update_submitted>
  <last_update_submitted_qc>January 25, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2007</last_update_posted>
  <keyword>PAR1 gene</keyword>
  <keyword>polymorphisms</keyword>
  <keyword>abortions</keyword>
  <keyword>reccurent abortions</keyword>
  <keyword>premature delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
    <mesh_term>Abortion, Habitual</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

